The combination of MAGI2-AS3 and ZFAS1 demonstrated a superior ability to discriminate between NSCLC and controls, suggesting that these lncRNAs could serve as biomarkers for NSCLC diagnosis [206]. This evidence concerns the gene ZFAS1 and non-small cell lung carcinoma.